chr12-116766871-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382266.1(RNFT2):āc.685C>Gā(p.Leu229Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,596,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001382266.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNFT2 | NM_001382266.1 | c.685C>G | p.Leu229Val | missense_variant | 6/11 | ENST00000257575.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNFT2 | ENST00000257575.9 | c.685C>G | p.Leu229Val | missense_variant | 6/11 | 5 | NM_001382266.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000582 AC: 13AN: 223508Hom.: 0 AF XY: 0.0000251 AC XY: 3AN XY: 119638
GnomAD4 exome AF: 0.0000270 AC: 39AN: 1444364Hom.: 0 Cov.: 30 AF XY: 0.0000195 AC XY: 14AN XY: 716590
GnomAD4 genome AF: 0.000256 AC: 39AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2024 | The c.685C>G (p.L229V) alteration is located in exon 6 (coding exon 5) of the RNFT2 gene. This alteration results from a C to G substitution at nucleotide position 685, causing the leucine (L) at amino acid position 229 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at